The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Spectrum Pharmaceuticals Inc

Nasdaq: SPPI
Last

(U.S.) $4.44

Today's change+0.28 +6.73%
Updated December 9 4:00 PM EST. Delayed by at least 15 minutes.
 

Spectrum Pharmaceuticals Inc

Nasdaq: SPPI
Last

(U.S.) $4.44

Today's change+0.28 +6.73%
Updated December 9 4:00 PM EST. Delayed by at least 15 minutes.

Spectrum Pharmaceuticals Inc crosses above 20-day moving average

Spectrum Pharmaceuticals Inc closed up sharply Friday, rallying (U.S.)$0.28 or 6.73% to (U.S.)$4.44 and crossing above its 20-day moving average. Over the last five days, shares have gained 11.00%, but are down 26.37% for the last year to date. Shares have underperformed the S&P 500 by 30.06% during the last year.

Key company metrics

  • Open(U.S.) $4.23
  • Previous close(U.S.) $4.16
  • High(U.S.) $4.56
  • Low(U.S.) $4.17
  • Bid / Ask(U.S.) $0.00 / (U.S.) $4.80
  • YTD % change-26.37%
  • Volume971,469
  • Average volume (10-day)903,696
  • Average volume (1-month)903,660
  • Average volume (3-month)882,091
  • 52-week range(U.S.) $3.21 to (U.S.) $7.74
  • Beta1.15
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.78
Updated December 9 4:00 PM EST. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue33344450
Total other revenue--------
Total revenue33344450
Gross profit24263744
Total cost of revenue10876
Total operating expense49565053
Selling / general / administrative19282221
Research & development13141515
Depreciation / amortization76610
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-16-22-6-3
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-18-24-9-4
Income after tax-17-24-9-4
Income tax, total0000
Net income-17-24-9-4
Total adjustments to net income--------
Net income before extra. items-17-24-9-4
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-17-24-9-4
Inc. avail. to common incl. extra. items-17-24-9-4
Diluted net income-17-24-9-4
Dilution adjustment--------
Diluted weighted average shares79696663
Diluted EPS excluding extraordinary itemsvalue per share-0.22-0.35-0.14-0.07
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share-0.22-0.35-0.14-0.07